BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by Humaniston Mar 16, 2023 2:40pm

164 Views

Post# 35343181

INTERVIEW WITH BIOV CEO link below ( re new acquisition)

https://ceo.ca/@accesswire/the-power-play-by-the-market-herald-releases-new-interviews-3bbb2

BioVaxys (CSE:BIOV) acquires TAETSoftware, completes financing

BioVaxys (BIOV) has acquired TAETSoftware, a Vancouver-based clinical studies management company. TAETSoftware is developing a software application for clinical study subjects to record and submit Adverse Drug Events reports to study sponsors in real time. Consideration includes 24,500,000 common shares, with an additional 2,500,000 common shares payable upon the successful testing of the application's beta version. CEO James Passin joined Coreena Robertson to discuss the news.
For the full interview with James Passin and to learn about BioVaxys, click here.
Interviews for The Power Play by The Market Herald are released daily. To learn more about the companies featured in The Power Play or to explore our other interviews visitThe Power Play by The Market Herald.
About The Market Herald
The Market Herald Canada is the leading source of authoritative breaking stock market news for self-directed investors. Our team of Canadian markets reporters, editors and technologists covers the entire listed company universe in Canada. We cover over 3,985 businesses, their people, their investors, and their customers. We write the stories that move the Canadian capital markets.

<< Previous

Bullboard Posts

Next >>

What's ahead for Apple after its rough start to 2024?